Correction: Cleavage of tropomodulin-3 by asparagine endopeptidase promotes cancer malignancy by actin remodeling and SND1/RhoA signaling

[RAW_REF_TEXT] Correction [/RAW_REF_TEXT] [RAW_REF_TEXT] Open Access [/RAW_REF_TEXT] [RAW_REF_TEXT] Published:04 August 2022 [/RAW_REF_TEXT] Correction: Cleavage of tropomodulin-3 by asparagine endopeptidase promotes cancer malignancy by actin remodeling and SND1/RhoA signaling [RAW_REF_TEXT] Binghong Chen1 na1, [/RAW_REF_TEXT] [RAW_REF_TEXT] Mengying Wang1 na1, [/RAW_REF_TEXT] [RAW_REF_TEXT] Junjun Qiu2 na1, [/RAW_REF_TEXT] [RAW_REF_TEXT] Keman Liao1 na1, [/RAW_REF_TEXT] [RAW_REF_TEXT] Wenrui Zhang1 na1, [/RAW_REF_TEXT] [RAW_REF_TEXT] Qi Lv3, [/RAW_REF_TEXT] [RAW_REF_TEXT] Chunhui Ma4, [/RAW_REF_TEXT] [RAW_REF_TEXT] Zhongrun Qian5, [/RAW_REF_TEXT] [RAW_REF_TEXT] Zhonggang Shi1, [/RAW_REF_TEXT] [RAW_REF_TEXT] Rong Liang6, [/RAW_REF_TEXT] [RAW_REF_TEXT] Yan Lin6, [/RAW_REF_TEXT] [RAW_REF_TEXT] Jiazhou Ye 7, [/RAW_REF_TEXT] [RAW_REF_TEXT] Yongming Qiu 1 & [/RAW_REF_TEXT] [RAW_REF_TEXT] Yingying Lin 1 [/RAW_REF_TEXT] Journal of Experimental & Clinical Cancer Research volume 41, Article number: 237 (2022) Cite this article [RAW_REF_TEXT] 161 Accesses [/RAW_REF_TEXT] [RAW_REF_TEXT] Metrics details [/RAW_REF_TEXT] The Original Article was published on 28 June 2022 Correction: J Exp Clin Cancer Res 41, 209 (2022) https://doi.org/10.1186/s13046-022-02411-4 Following publication of the original article [1], an error was identified in Fig. 2; specifically: Scale bar, 40 μm. D Histochemistry score (H-score) of Tmod3 in LGG and HGG of the tissue array; the data are shown as the mean ± s.d. E Kaplan–Meier survival plots showing survival rates of the patients in the indicated groups with high or low Tmod3 H-scores. Correction Open Access Published:04 August 2022 [/RAW_REF_TEXT] Correction: Cleavage of tropomodulin-3 by asparagine endopeptidase promotes cancer malignancy by actin remodeling and SND1/RhoA signaling [RAW_REF_TEXT] Binghong Chen1 na1, Mengying Wang1 na1, Junjun Qiu2 na1, Keman Liao1 na1, Wenrui Zhang1 na1, Qi Lv3, Chunhui Ma4, Zhongrun Qian5, Zhonggang Shi1, Rong Liang6, Yan Lin6, Jiazhou Ye 7, Yongming Qiu 1 & Yingying Lin 1 [/RAW_REF_TEXT] Journal of Experimental & Clinical Cancer Research volume 41, Article number: 237 (2022) Cite this article [RAW_REF_TEXT] 161 Accesses Metrics details